Compare CDW & COO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CDW | COO |
|---|---|---|
| Founded | 1984 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Ophthalmic Goods |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.9B | 16.1B |
| IPO Year | 1993 | N/A |
| Metric | CDW | COO |
|---|---|---|
| Price | $139.81 | $82.52 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 11 |
| Target Price | ★ $185.13 | $88.55 |
| AVG Volume (30 Days) | 1.9M | ★ 3.3M |
| Earning Date | 02-04-2026 | 12-04-2025 |
| Dividend Yield | ★ 1.80% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 7.91 | 1.87 |
| Revenue | ★ $22,099,100,000.00 | $4,092,400,000.00 |
| Revenue This Year | $6.77 | $6.56 |
| Revenue Next Year | $2.85 | $5.32 |
| P/E Ratio | ★ $17.66 | $44.18 |
| Revenue Growth | ★ 6.09 | 5.06 |
| 52 Week Low | $135.63 | $61.78 |
| 52 Week High | $222.92 | $100.24 |
| Indicator | CDW | COO |
|---|---|---|
| Relative Strength Index (RSI) | 40.37 | 63.62 |
| Support Level | $138.37 | $81.92 |
| Resistance Level | $146.15 | $83.64 |
| Average True Range (ATR) | 3.47 | 1.74 |
| MACD | -0.51 | -0.08 |
| Stochastic Oscillator | 16.91 | 74.03 |
CDW Corp is a multi-brand provider of information technology ("IT") solutions to small, medium, and large business, government, education, and healthcare customers in the United States, the United Kingdom, and Canada. The company's broad array of offerings ranges from discrete hardware and software products to integrated IT solutions and services that include on-premise and cloud capabilities across hybrid infrastructure, digital experience, and security. The company has five operating segments namely, Corporate, Small Business, Public, CDW UK, and CDW Canada. The Corporate segment generates the majority of its revenue and serves USA private sector business customers.
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.